Herpes Simplex Virus 1/2 (HSV1/2) IgG with Reflex to HSV-2 Inhibition Build info

Synonyms

• HERPES SIMPLEX VIRUS 1/2 IGG WITH REFLEX TO HSV-2 INHIBITION
• HSV12IN
• LAB14289

Short Name

HERPES SIMPLEX VIRUS 1/2 IGG WITH REFLEX TO HSV-2 INHIBITION

Procedure Master Number

LAB14289

Procedure ID

185173

Clinical Info

Herpes Simplex Virus 1 and 2 (IgG), with Reflex to HSV-2 Inhibition - Herpes Simplex Virus (HSV) is responsible for several clinically significant human viral diseases, with severity ranging from inapparent to fatal. Clinical manifestations include genital tract infections, neonatal herpes, meningoencephalitis, keratoconjunctivitis, and gingivostomatitis. There are two HSV serotypes that are closely related antigenically. HSV type 2 is more commonly associated with genital tract and neonatal infections, while HSV type 1 is more commonly associated with infections of non-genital sites. Specific typing is not usually required for diagnosis or treatment. The mean time to seroconversion using the type specific assay is 25 days. The performance of this assay has not been established for use in a pediatric population, for neonatal screening, or for testing of immunocompromised patients.

Specimen Type

Blood

Container

Gold Top Tube

Collection Instructions

Container/Tube: Gold Top Tube
Specimen: 2 mL serum (1 mL min)
Transport Temperature: Room Temperature
Stability: 7 Days Room Temperature
14 Days Refrigerated
30 Days Frozen

Transport Instructions

Room Temperature

Specimen Stability

7 Days Room Temperature
14 Days Refrigerated
30 Days Frozen

Methodology

Immunoassay (IA)

Days Performed

TAT: 2 - 3 Days

Performing Laboratory

Quest Diagnostics Nichols Institute, Chantilly, VA
Herpes Simplex Virus 2 (IgG) is >1.09, then HSV-2 Inhibition Study will be performed at an additional charge (CPT code(s): 86696).

CPT

86695
86696

PDM

2159704

Results